+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Autologous Wound Patches Market Size, Share & Trends Analysis Report by Type (Platelet Rich Plasma), by Application (Chronic Wounds, Acute Wounds), by End Use (Hospitals, Clinics), by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 90 Pages
  • April 2022
  • Region: Global
  • Grand View Research
  • ID: 5595894
The gloabl autologous wound patches market is anticipated to reach USD 152.76 million by 2030, registering a CAGR of 9.05% from 2022 to 2030. This can be attributed to the increase in the number of people suffering from various chronic diseases such as diabetes as a result the number of people suffering from diabetic foot ulcers is anticipated to increase. For instance, as per International Diabetes Federation, approximately 537 million adults are expected to be living with diabetes. Moreover, as per a similar source, this number is projected to increase to 643 million by 2030.



Furthermore, according to NCBI, 15 to 25% of people suffering from diabetes mellitus may develop a diabetic foot ulcer during their lifetime. Thus, an increasing number of diabetic populations may lead to a rise in number of diabetic foot ulcers patients, thereby boosting the market during the forecast period.

Similarly, there has been a rise in number of people suffering from venous leg ulcers. For instance, as per Biomed Central, venous leg ulcers represent about 60 to 80% of all leg ulcerations which occurs due to venous disease. Furthermore, according to a similar source, the estimated annual health care cost for treatment of venous leg ulcers is USD 2.24 billion yearly. Thus, with an increase in the number of such chronic diseases, the market is expected to impel.

In addition, an increase in surgical procedures is expected to increase the demand for autologous wound patches during the forecast period. For instance, as per Jama Network, there were an estimated 13,108,567 surgical procedures identified in 2019 in the U.S. Similarly, according to the Australian Institute of Health & Welfare, 754,600 patients were admitted for surgery in a public hospital. The increase in number of surgical procedures poses a threat of surgical wounds. Thus, the market is expected to grow during the forecast period.

Furthermore, decline in the population suffering from COVID-19 is anticipated to boost the growth of autologous wound patches market. Companies in the market are opting for various strategies such as partnerships, product showcases, and distribution agreements to enhance their customer reach during post-COVID-19 period.

For instance, in October 2021, RedDress announced a partnership with MediGroup. MediGroup is one of the largest non-acute GPO which represents physician centers, surgical centers & clinics. This partnership is expected to help the company provide its innovative wound care system ActiGraft to MediGroup members, which will increase the company’s reach towards the target population. Therefore, such instances are expected to boost the growth of the market during the forecast period.

Autologous Wound Patches Market Report Highlights

  • In terms of type, platelet rich fibrin segment held the largest share of 55.33% in 2021, owing to its compatible nature and better outcome.
  • On the basis of application, the acute wounds segment held the largest market share in 2021. However, the chronic wounds segment is expected to expand at the highest CAGR of 9.18%. This can be attributed to the increase in number of people suffering from various chronic ailments such as venous leg ulcers, diabetic foot ulcers, and pressure ulcers.
  • On the basis of end-use, the hospitals segment held the largest market share in 2021, whereas, the ambulatory surgical center segment is anticipated to register the fastest CAGR of 9.31% during the forecast period. This can be attributed to the increase in number of ASCs and a rise in number of surgeries performed in ambulatory surgical centers.
  • North America is anticipated to dominate the global market during the forecast period owing to the rising number of surgeries and the presence of a large population base in the region. However, Asia-Pacific is projected to witness the fastest growth rate of 9.30% during the forecast period.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Type
1.1.2 Application
1.1.3 End-Use
1.1.4 Regional Scope
1.1.5 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Autologous Wound Patches Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Key End-Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Global Increase In Prevalence Of Chronic and Acute Wounds
3.5.1.2 Increasing Number Of Ambulatory Surgical Centers (Ascs)
3.5.1.3 Increasing Number Of Traumatic Accidents
3.5.1.4 Availability Of Favorable Reimbursement Policies
3.5.2 Market Restraints Analysis
3.5.2.1 High Cost Of Autologous Wound Patches
3.5.2.2 Availability Of SuiTable Alternative For Autologus Wound Patches
3.5.2.3 Low Awareness About Autologous Wound Patches
3.6 Autologous Wound Patches: Market Analysis Tools
3.6.1 Industry Analysis-Porter’s
3.6.2 Swot Analysis, by Pest
3.7 Impact of COVID-19 on Market
Chapter 4 Autologous Wound Patches Market: Segment Analysis, by Type, 2018-2030 (USD Million)
4.1 Definition and Scope
4.2 Type Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Autologous Wound Patches Market, by Type, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
4.5.1 Platelet Rich Plasma
4.5.1.1 Platelet Rich Plasma Market, 2018-2030 (USD Million)
4.5.2 Platelet Rich Fibrin
4.5.2.1 Platelet Rich Fibrin Market, 2018-2030 (USD Million)
Chapter 5 Autologus Wound Patches Market: Segment Analysis, by Application, 2018-2030 (USD Million)
5.1 Definition and Scope
5.2 Application Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Autologous Wound Patches Market, by Application, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analysis, 2018 To 2030
5.5.1 Chronic Wounds
5.5.1.1 Chronic Wounds Market, 2018-2030 (USD Million)
5.5.1.1.1 Diabetic Foot Ulcers Market, 2018-2030 (USD Million)
5.5.1.1.2 Pressure Ulcers Market, 2018-2030 (USD Million)
5.5.1.1.3 Venous Leg Ulcers Market, 2018-2030 (USD Million)
5.5.1.1.4 Other Chronic Wounds Market, 2018-2030 (USD Million)
5.5.2 Acute Wounds
5.5.2.1 Acute wounds market, 2018-2030 (USD Million)
5.5.2.1.1 Surgical & traumatic wounds market, 2018-2030 (USD Million)
5.5.2.1.2 Burns market, 2018-2030 (USD Million)
Chapter 6 Autologous Wound Patches Market: Segment Analysis, by End-use, 2018-2030 (USD Million)
6.1 Definition and Scope
6.2 End-use Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global Autologous Wound Patches Market, by End-use, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.5.1 Hospitals
6.5.1.1 Hospitals Market, 2018-2030 (USD Million)
6.5.2 Clinics
6.5.2.1 Clinics Market, 2018-2030 (USD Million)
6.5.3 Ambulatory Surgical Center
6.5.3.1 Ambulatory Surgical Center Market, 2018-2030 (USD Million)
Chapter 7 Autologous Wound Patches Market: Regional Market Analysis, by Type, by Application, by End-use 2018-2030 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2021 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2030
7.6 North America
7.6.1 North America Autologous Wound Patches Market, 2018-2030 (USD Million)
7.6.2 U.S.
7.6.2.1 U.S. Autologous Wound Patches Market, 2018-2030 (USD Million)
7.6.3 Canada
7.6.3.1 Canada Autologous Wound Patches Market, 2018-2030 (USD Million)
7.7 Europe
7.7.1 Europe Autologous Wound Patches Market, 2018-2030 (USD Million)
7.7.2 UK
7.7.2.1 UK Autologous Wound Patches Market, 2018-2030 (USD Million)
7.7.3 Germany
7.7.3.1 Germany Autologous Wound Patches Market, 2018-2030 (USD Million)
7.7.4 France
7.7.4.1 France Autologous Wound Patches Market, 2018-2030 (USD Million)
7.7.5 Italy
7.7.5.1 Italy autologous wound patches market, 2018-2030 (USD Million)
7.7.6 SPAIN
7.7.6.1 Spain autologous wound patches market, 2018-2030 (USD Million)
7.8 Asia Pacific
7.8.1 Asia Pacific Autologous Wound Patches Market, 2018-2030 (USD Million)
7.8.2 Japan
7.8.2.1 Japan Autologous Wound Patches Market, 2018-2030 (USD Million)
7.8.3 China
7.8.3.1 China (Mainland) Autologous Wound Patches Market, 2018-2030 (USD Million)
7.8.4 India
7.8.4.1 India Autologous Wound Patches Market, 2018-2030 (USD Million)
7.8.5 Australia
7.8.5.1 Australia Autologous Wound Patches Market, 2018-2030 (USD Million)
7.8.6 South Korea
7.8.6.1 South Korea Autologous Wound Patches Market, 2018-2030 (USD Million)
7.9 Latin America
7.9.1 Latin America Autologous Wound Patches Market, 2018-2030 (USD Million)
7.9.2 Brazil
7.9.2.1 Brazil Autologous Wound Patches Market, 2018-2030 (USD Million)
7.9.3 Mexico
7.9.3.1 Mexico Autologous Wound Patches Market, 2018-2030 (USD Million)
7.9.4 Argentina
7.9.4.1 Argentina Autologous Wound Patches Market, 2018-2030 (USD Million)
7.9.5 Colombia
7.9.5.1 Colombia Autologous Wound Patches Market, 2018-2030 (USD Million)
7.10 MEA
7.10.1 MEA Autologous Wound Patches Market, 2018-2030 (USD Million)
7.10.2 South Africa
7.10.2.1 South Africa Autologous Wound Patches Market, 2018-2030 (USD Million)
7.10.3 Saudi Arabia
7.10.3.1 Saudi Arabia Autologous Wound Patches Market, 2018-2030 (USD Million)
7.10.4 UAE
7.10.4.1 UAE autologous wound patches market, 2018-2030 (USD Million)
Chapter 8 Autologous Wound Patches Market-Competitive Analysis
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Vendor Landscape
8.3.1 Key Company Market Share Analysis, 2021
8.3.2 Major Deals and Strategic Alliances
8.3.2.1 New Product Launch
8.3.2.2 Expansion
8.3.2.3 Acquistion
8.3.3 Market Entry Strategies
8.4 Company Profiles
8.4.1 REAPPLIX
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 PRP CONCEPTS
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 REDDRESS
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.4 NUO THERAPEUTICS
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.3 Strategic initiatives

Companies Mentioned

  • Reapplix
  • Prp Concepts
  • Reddress
  • Nuo Therapeutics

Methodology

Loading
LOADING...

Table Information